CHPA Seeks Enforcement Discretion, Clarifications On OTC Analgesic Rule
This article was originally published in The Tan Sheet
Executive Summary
The Consumer Healthcare Products Association says the liver damage warning for acetaminophen-containing products in the OTC analgesics final rule potentially is inaccurate for combination products and asks FDA to allow firms to use alternate language
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning